Xact Kapitalforvaltning’s Acceleron Pharma XLRN Stock Holding History

Xact Kapitalforvaltning’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$703K	Hold	7,823	–	–	0.02%	613
2019 Q4	$415K	Hold	7,823	–	–	0.01%	1084
2019 Q3	$309K	Hold	7,823	–	–	0.01%	1185
2019 Q2	$321K	Hold	7,823	–	–	0.01%	1184
2019 Q1	$364K	Hold	7,823	–	–	0.01%	1109
2018 Q4	$341K	Hold	7,823	–	–	0.01%	1154
2018 Q3	$448K	Hold	7,823	–	–	0.01%	1058
2018 Q2	$380K	Buy	7,823 +1,000	+15%	+$36.4K	0.01%	1154
2018 Q1	$267K	Buy	6,823 +1,700	+33%	+$72.3K	0.01%	1322
2017 Q4	$217K	Buy	+5,123	New	+$192K	0.01%	1199

Other funds holding XLRN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Xact Kapitalforvaltning's XLRN Position: Q1 2020 in Review

Xact Kapitalforvaltning held its Acceleron Pharma (XLRN) position steady in Q1 2020 at 7,823 shares worth $703K. The position accounts for 0.02% of the portfolio, ranked #613.

Xact Kapitalforvaltning first reported a position in XLRN in Q4 2017 and has held it in 10 quarters since. 217 funds tracked by Wall St. Rank hold XLRN as of Q1 2020.

Xact Kapitalforvaltning held 7,823 shares of Acceleron Pharma worth $703K as of Q1 2020.
Xact Kapitalforvaltning left its Acceleron Pharma share count unchanged in Q1 2020.
Acceleron Pharma made up 0.02% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #613 holding.
Xact Kapitalforvaltning first reported a position in Acceleron Pharma in Q4 2017 and has held it in 10 quarters since.
217 funds tracked by Wall St. Rank held Acceleron Pharma as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.